Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303K CFTR mutation

• Martina Gentzsch,
• Brooke Baker,
• Deborah M. Cholon,
• Charissa W. Kam,
• Cameron J. McKinzie,
• Katherine A. Despotes,
• Susan E. Boyles,
• Nancy L. Quinney,
• Charles R. Esther Jr,
• Carla M.P. Ribeiro

Affiliations

Martina Gentzsch

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA

Brooke Baker

Department of Pharmacy, Duke University Medical Center, Durham, NC, USA

Deborah M. Cholon

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA

Charissa W. Kam

Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA

Cameron J. McKinzie

Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC, USA

Katherine A. Despotes

Department of Pediatrics, The University of North Carolina, Chapel Hill, NC, USA

Susan E. Boyles

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA

Nancy L. Quinney

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA

Charles R. Esther Jr

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA

Carla M.P. Ribeiro

Marsico Lung Institute and Cystic Fibrosis Research Center, The University of North Carolina, Chapel Hill, NC, USA